AstraZeneca Pharma India Ltd share price
You have to be logged in to add this to Watchlist.- ₹8,301.35(0.60%)January 19, 2026 12:07:33 PM IST
- NSE
- BSE
- Vol : 3.20 K (NSE + BSE)Last 20 day avg : 17.13 K
AstraZeneca Pharma India Ltd is trading 0.60% upper at Rs 8,301.35 as compared to its last closing price. AstraZeneca Pharma India Ltd has been trading in the price range of 8,302.80 & 8,050.85. The company posted a net profit of 54.22 Crores in its last quarter.Listed peers of AstraZeneca Pharma India Ltd include Divi's Laboratories (-1.71%), Sun Pharmaceutical Industries (0.35%), Torrent Pharmaceuticals (1.60%).The Mutual Fund holding in AstraZeneca Pharma India Ltd was at 5.00% in 30 Sep 2025. The MF holding has increased from the last quarter. The FII holding in AstraZeneca Pharma India Ltd was at 2.74% in 30 Sep 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Jan 19, 2026, 06:51 AM UTC
- BetaLow volatility0.51Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.05The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.35Annual dividends as a percentage of the stock price.
- P/BHigher than historical values29.75The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values115.06Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bearish | 6,127.65 | -1.71 | 1,62,669.86 | 78.61 | 11.52 | 0.46 | 0.01 |
| Sun Pharmaceutical Industries | Bearish | 1,675.00 | 0.35 | 4,01,879.14 | 36.24 | 5.77 | 0.92 | 0.50 |
| Torrent Pharmaceuticals | Bullish | 4,082.95 | 1.60 | 1,38,180.03 | 67.32 | 17.1 | 0.83 | 17.62 |
| Cipla | Bearish | 1,390.95 | -0.50 | 1,12,316.85 | 22.95 | 3.87 | 0.87 | 0.81 |
| Dr Reddy's Laboratories | Bearish | 1,172.05 | -0.30 | 97,809.95 | 18.63 | 3.14 | 0.63 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE203A01020
- BSE Code506820
- NSE Code
AstraZeneca Pharma India Ltd is trading at 8301.35 as on Mon Jan 19 2026 06:37:33. This is 0.60% upper as compared to its previous closing price of 8251.95.
The market capitalization of AstraZeneca Pharma India Ltd is 20703.08 Cr as on Mon Jan 19 2026 06:37:33.
The 52 wk high for AstraZeneca Pharma India Ltd is 10653.05 whereas the 52 wk low is 6501.60
AstraZeneca Pharma India Ltd can be analyzed on the following key metrics -
- TTM P/E:
- Sector P/E: -
- Dividend Yield: %
- D/E ratio: -
AstraZeneca Pharma India Ltd reported a net profit of 115.74 Cr in 2025.
The Mutual Fund Shareholding was 5.00% at the end of 30 Sep 2025.
EQUITY QUICK LINKS
AstraZeneca Pharma India Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.